Evidence map›Paper›PMID 40608796›Full record

ArticlePloS one2025

Bifurcation study of a tumor-immune system with chemotherapy.

Abdelhamid Ajbar, Rubayyi T Alqahtani, Khalid Alhumaizi

Abstract read
In one paragraph

Article in PloS one, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Abdelhamid AjbarDepartment of Chemical Engineering Department, College of Engineering, King Saud University, Riyadh, Saudi Arabia.ORCID https://orcid.org/0000-0002-3443-5411
Rubayyi T AlqahtaniDepartment of Mathematics and Statistics, College of Science, Imam Mohammad Ibn Saud Islamic University (IMSIU), Riyadh, Saudi Arabia.
Khalid AlhumaiziDepartment of Chemical Engineering Department, College of Engineering, King Saud University, Riyadh, Saudi Arabia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Understanding the dynamics of cancer cell growth, the interplay between tumor and immune cells, and the efficacy of chemotherapy are pivotal areas of focus in cancer research. In this regard, mathematical modeling can provide significant insights. This study re-examines a classical two-dimensional model of tumor-immune cell interactions where the tumor's growth rate is assumed to adhere to von Bertalanffy's model instead of the logistic model. We investigate the model both without chemotherapy and with treatment. The equilibrium points are identified, classified, and their stability analyzed. Our results reveal that the model can demonstrate a broad spectrum of behaviors, including bi-stability and multi-stability as well as regions of stable periodic behavior. We establish analytical conditions for the existence of Hopf points. Furthermore, we assess the impact of model parameters on the various behavior predicted by the model. This mathematical investigation can provide general guidance on treatment strategies.

Indexed as

Antineoplastic AgentsImmune SystemNeoplasmsCell ProliferationHumansModels, BiologicalModels, TheoreticalAntineoplastic Agents

Identifiers

PMID40608796
PMCPMC12225868

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.